Xuefei Shi Jia Zhou Caihua Qian Liliang Gao Bin Wang Xueren Feng
10.2147/OTT.S257431
Onco Targets Ther
2020 Jul 13;13:6789-6793.
egfr-mutant non–small-cell lung cancer first-line egfr-tki therapy oligoprogressive disease radiofrequency ablation
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32764966/
Case Reports
PMC7369376
32764966
Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports
2020